Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Obesity Is Associated with Risk of Progression for Low-risk Prostate Cancers Managed Expectantly.

Bhindi B, Kulkarni GS, Finelli A, Alibhai SM, Hamilton RJ, Toi A, van der Kwast TH, Evans A, Hersey K, Jewett MA, Zlotta AR, Trachtenberg J, Fleshner NE.

Eur Urol. 2014 Jun 18. pii: S0302-2838(14)00526-0. doi: 10.1016/j.eururo.2014.06.005. [Epub ahead of print]

PMID:
24954793
[PubMed - as supplied by publisher]
2.

Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial.

Godtman RA, Holmberg E, Khatami A, Stranne J, Hugosson J.

Eur Urol. 2013 Jan;63(1):101-7. doi: 10.1016/j.eururo.2012.08.066. Epub 2012 Sep 5.

PMID:
22980443
[PubMed - indexed for MEDLINE]
3.

Impact of 5α-reductase inhibitors on men followed by active surveillance for prostate cancer.

Finelli A, Trottier G, Lawrentschuk N, Sowerby R, Zlotta AR, Radomski L, Timilshina N, Evans A, van der Kwast TH, Toi A, Jewett MA, Trachtenberg J, Fleshner NE.

Eur Urol. 2011 Apr;59(4):509-14. doi: 10.1016/j.eururo.2010.12.018. Epub 2010 Dec 28.

PMID:
21211899
[PubMed - indexed for MEDLINE]
4.

Predictors of Pathologic Progression on Biopsy Among Men on Active Surveillance for Localized Prostate Cancer: The Value of the Pattern of Surveillance Biopsies.

Cary KC, Cowan JE, Sanford M, Shinohara K, Perez N, Chan JM, Meng MV, Carroll PR.

Eur Urol. 2013 Sep 9. pii: S0302-2838(13)00987-1. doi: 10.1016/j.eururo.2013.08.060. [Epub ahead of print]

PMID:
24035632
[PubMed - as supplied by publisher]
5.

A Negative Confirmatory Biopsy Among Men on Active Surveillance for Prostate Cancer Does Not Protect Them from Histologic Grade Progression.

Wong LM, Alibhai SM, Trottier G, Timilshina N, Van der Kwast T, Zlotta A, Lawrentschuk N, Kulkarni G, Hamilton R, Ferrara S, Margel D, Trachtenberg J, Jewett MA, Toi A, Evans A, Fleshner NE, Finelli A.

Eur Urol. 2013 May 2. pii: S0302-2838(13)00423-5. doi: 10.1016/j.eururo.2013.04.038. [Epub ahead of print]

PMID:
23664820
[PubMed - as supplied by publisher]
6.

Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.

Iremashvili V, Manoharan M, Rosenberg DL, Soloway MS.

BJU Int. 2013 Apr;111(4):574-9. doi: 10.1111/j.1464-410X.2012.11127.x. Epub 2012 May 4.

PMID:
22564446
[PubMed - indexed for MEDLINE]
7.

Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer.

Adamy A, Yee DS, Matsushita K, Maschino A, Cronin A, Vickers A, Guillonneau B, Scardino PT, Eastham JA.

J Urol. 2011 Feb;185(2):477-82. doi: 10.1016/j.juro.2010.09.095. Epub 2010 Dec 17.

PMID:
21167529
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer.

Bul M, van den Bergh RC, Zhu X, Rannikko A, Vasarainen H, Bangma CH, Schröder FH, Roobol MJ.

BJU Int. 2012 Dec;110(11):1672-7. doi: 10.1111/j.1464-410X.2012.11434.x. Epub 2012 Aug 29.

PMID:
22928973
[PubMed - indexed for MEDLINE]
9.

Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer.

Ross AE, Feng Z, Pierorazio PM, Landis P, Walsh PC, Carter HB, Trock BJ, Schaeffer EM.

BJU Int. 2012 Sep;110(5):651-7. doi: 10.1111/j.1464-410X.2011.10875.x. Epub 2012 Jan 30.

PMID:
22289613
[PubMed - indexed for MEDLINE]
10.

The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillance.

Ploussard G, de la Taille A, Bayoud Y, Durand X, Terry S, Xylinas E, Allory Y, Vacherot F, Abbou CC, Salomon L.

Eur Urol. 2012 Feb;61(2):356-62. doi: 10.1016/j.eururo.2011.07.041. Epub 2011 Jul 21.

PMID:
21803484
[PubMed - indexed for MEDLINE]
11.

Dissecting the Association Between Metabolic Syndrome and Prostate Cancer Risk: Analysis of a Large Clinical Cohort.

Bhindi B, Locke J, Alibhai SM, Kulkarni GS, Margel DS, Hamilton RJ, Finelli A, Trachtenberg J, Zlotta AR, Toi A, Hersey KM, Evans A, van der Kwast TH, Fleshner NE.

Eur Urol. 2014 Feb 14. pii: S0302-2838(14)00125-0. doi: 10.1016/j.eururo.2014.01.040. [Epub ahead of print]

PMID:
24568896
[PubMed - as supplied by publisher]
12.

Prostate specific antigen velocity risk count predicts biopsy reclassification for men with very low risk prostate cancer.

Patel HD, Feng Z, Landis P, Trock BJ, Epstein JI, Carter HB.

J Urol. 2014 Mar;191(3):629-37. doi: 10.1016/j.juro.2013.09.029. Epub 2013 Sep 20.

PMID:
24060641
[PubMed - indexed for MEDLINE]
13.

Regular Transition Zone Biopsy during Active Surveillance for Prostate Cancer May Improve Detection of Pathological Progression.

Wong LM, Toi A, Van der Kwast T, Trottier G, Alibhai SM, Timilshina N, Evans A, Zlotta A, Fleshner N, Finelli A.

J Urol. 2014 Apr 15. pii: S0022-5347(14)03336-9. doi: 10.1016/j.juro.2014.04.010. [Epub ahead of print]

PMID:
24742593
[PubMed - as supplied by publisher]
14.

Predictors of pathological progression among men with localized prostate cancer undergoing active surveillance: a sub-analysis of the REDEEM study.

Margel D, Nandy I, Wilson TH, Castro R, Fleshner N.

J Urol. 2013 Dec;190(6):2039-45. doi: 10.1016/j.juro.2013.06.051. Epub 2013 Jun 29.

PMID:
23820059
[PubMed - indexed for MEDLINE]
15.

A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling.

Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll PR.

Eur Urol. 2014 May 16. pii: S0302-2838(14)00414-X. doi: 10.1016/j.eururo.2014.05.004. [Epub ahead of print]

PMID:
24836057
[PubMed - as supplied by publisher]
16.

Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.

Keto CJ, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, Freedland SJ.

BJU Int. 2012 Aug;110(4):492-8. doi: 10.1111/j.1464-410X.2011.10754.x. Epub 2011 Nov 17.

PMID:
22094083
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Active surveillance for low-risk prostate cancer worldwide: the PRIAS study.

Bul M, Zhu X, Valdagni R, Pickles T, Kakehi Y, Rannikko A, Bjartell A, van der Schoot DK, Cornel EB, Conti GN, Boevé ER, Staerman F, Vis-Maters JJ, Vergunst H, Jaspars JJ, Strölin P, van Muilekom E, Schröder FH, Bangma CH, Roobol MJ.

Eur Urol. 2013 Apr;63(4):597-603. doi: 10.1016/j.eururo.2012.11.005. Epub 2012 Nov 12.

PMID:
23159452
[PubMed - indexed for MEDLINE]
18.

A multi-institutional evaluation of active surveillance for low risk prostate cancer.

Eggener SE, Mueller A, Berglund RK, Ayyathurai R, Soloway C, Soloway MS, Abouassaly R, Klein EA, Jones SJ, Zappavigna C, Goldenberg L, Scardino PT, Eastham JA, Guillonneau B.

J Urol. 2013 Jan;189(1 Suppl):S19-25; discussion S25. doi: 10.1016/j.juro.2012.11.023.

PMID:
23234624
[PubMed - indexed for MEDLINE]
19.

Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density.

Umbehr MH, Platz EA, Peskoe SB, Bhavsar NA, Epstein JI, Landis P, Partin AW, Carter HB.

BJU Int. 2014 Apr;113(4):561-7. doi: 10.1111/bju.12131. Epub 2013 Jun 7.

PMID:
23746233
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Role of immediate confirmatory prostate biopsy to ensure accurate eligibility for active surveillance.

Motamedinia P, RiChard JL, McKiernan JM, DeCastro GJ, Benson MC.

Urology. 2012 Nov;80(5):1070-4. doi: 10.1016/j.urology.2012.07.049.

PMID:
23107398
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk